$ORIC

$13.85▲ -0.1% YTD

5 SEC 13D/G filings tracked · Last updated Oct 23, 2026

Filing History

ORIC ▼ -0.1% - ORIC Pharmaceuticals, Inc.

CP $13.85▲ -0.1%Oct 23, 2026 · ThinkSabio Blog

$ORIC - ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen…

News

ORIC ▼ -0.1% - ORIC Pharmaceuticals, Inc.

CP $13.85▲ -0.1%Oct 23, 2026 · ThinkSabio Blog

$ORIC - ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress…

News

ORIC ▲ +1.1% - ORIC Pharmaceuticals, Inc.

CP $12.50▲ +1.1%Oct 19, 2026 · ThinkSabio Blog

$ORIC - ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026…

News

ORIC ▲ +2.4% - ORIC Pharmaceuticals, Inc.

CP $12.49▲ +2.4%Oct 5, 2026 · ThinkSabio Blog

$ORIC - ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical D…

News

ORIC ▲ +1.9% - ORIC Pharmaceuticals, Inc.

CP $13.13▲ +1.9%Sep 2, 2026 · ThinkSabio Blog

$ORIC - ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences…